While Institutions Invested in Omeros Corporation (NASDAQ:OMER) Benefited From Last Week's 54% Gain, Retail Investors Stood to Gain the Most
While Institutions Invested in Omeros Corporation (NASDAQ:OMER) Benefited From Last Week's 54% Gain, Retail Investors Stood to Gain the Most
Key Insights
主要见解
- Significant control over Omeros by retail investors implies that the general public has more power to influence management and governance-related decisions
- A total of 25 investors have a majority stake in the company with 44% ownership
- Institutions own 43% of Omeros
- 散户投资者对奥麦罗制药的显著控制意味着公众在影响管理和治理相关决策方面拥有更大的权力。
- 共有25名投资者拥有该公司的多数股份,占股44%。
- 机构持有奥麦罗制药43%的股份。
To get a sense of who is truly in control of Omeros Corporation (NASDAQ:OMER), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, around 53% to be precise, is retail investors. Put another way, the group faces the maximum upside potential (or downside risk).
要了解谁真正控制着奥麦罗制药公司(纳斯达克:OMER),了解该业务的所有权结构是很重要的。持有该公司最多股份的团体,大约占53%,是散户投资者。换句话说,该团体面临着最大上行潜力(或下行风险)。
Following a 54% increase in the stock price last week, retail investors profited the most, but institutions who own 43% stock also stood to gain from the increase.
在上周股票价格上涨54%后,零售投资者利润最多,但持有43%股票的机构也从中获利。
In the chart below, we zoom in on the different ownership groups of Omeros.
在下面的图表中,我们仔细查看奥麦罗制药的不同持股群体。
What Does The Institutional Ownership Tell Us About Omeros?
机构持股告诉我们关于奥麦罗制药什么?
Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.
许多机构衡量其业绩的标准是一个近似于当地市场的指数。因此,他们通常更加关注包括在主要指数中的公司。
We can see that Omeros does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Omeros, (below). Of course, keep in mind that there are other factors to consider, too.
我们可以看到奥麦罗制药确实有机构投资者,他们持有公司股票的一部分。这表明该公司在投资社区中有一定程度的可信度。然而,最好小心依赖于机构投资者所带来的所谓验证。机构投资者也是会犯错误的。如果两家大型机构投资者同时试图抛售同一股票,股票价格大幅下跌并不罕见。因此,查看奥麦罗制药过去的盈利轨迹是值得的(见下文)。当然,还要记住其他因素也很重要。
We note that hedge funds don't have a meaningful investment in Omeros. Looking at our data, we can see that the largest shareholder is Ingalls & Snyder, LLC with 7.9% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 7.1% and 5.6%, of the shares outstanding, respectively. Additionally, the company's CEO Gregory Demopulos directly holds 3.5% of the total shares outstanding.
我们注意到对奥麦罗制药的对冲基金没有进行有意义的投资。根据我们的数据,最大的股东是Ingalls & Snyder, LLC,持有7.9%的流通股份。同时,第二大和第三大股东分别持有7.1%和5.6%的流通股份。此外,该公司的CEO Gregory Demopulos直接持有3.5%的总流通股份。
A deeper look at our ownership data shows that the top 25 shareholders collectively hold less than half of the register, suggesting a large group of small holders where no single shareholder has a majority.
对我们的所有权数据进行更深入的研究表明,前25名股东的持股总额不到注册表的一半,表明有一个小股东的大群体,其中没有单个股东拥有多数股份。
Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There is a little analyst coverage of the stock, but not much. So there is room for it to gain more coverage.
研究机构所有权是衡量和筛选股票预期表现的好方法。研究分析师的看法也可以达到同样的效果。股票的分析师覆盖率很低,但不多。因此,可以有更多的空间来增加其覆盖范围。
Insider Ownership Of Omeros
奥麦罗制药的内部持股情况
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.
虽然内部人员的具体定义可能是主观的,但几乎所有人都认为董事会成员是内部人员。公司管理层应向董事会回答问题,后者应代表股东的利益。值得注意的是,有时高层管理人员也会成为董事会成员。
Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.
大多数人认为内部所有权是积极的,因为它可以表示董事会与其他股东的利益相一致。但是,在某些场合下,这个团体的权力过于集中。
Our most recent data indicates that insiders own some shares in Omeros Corporation. It has a market capitalization of just US$243m, and insiders have US$11m worth of shares, in their own names. Some would say this shows alignment of interests between shareholders and the board. But it might be worth checking if those insiders have been selling.
我们最新的数据表明,内部人持有奥麦罗制药的一些股票。其市值仅为24300万美元,内部人名下的股票价值为1100万美元。有些人会说这表明股东与董事会之间的利益一致。但值得检查一下这些内部人是否有在卖出股票。
General Public Ownership
一般大众所有权
The general public -- including retail investors -- own 53% of Omeros. This size of ownership gives investors from the general public some collective power. They can and probably do influence decisions on executive compensation, dividend policies and proposed business acquisitions.
公众,包括散户投资者,拥有奥麦罗制药53%的股份。这种规模的持股赋予了公众投资者一定的集体权力。他们可以并且很可能会影响高管薪酬、分红政策和拟议的业务收购决策。
Next Steps:
下一步:
It's always worth thinking about the different groups who own shares in a company. But to understand Omeros better, we need to consider many other factors. Like risks, for instance. Every company has them, and we've spotted 5 warning signs for Omeros (of which 4 are concerning!) you should know about.
始终值得考虑不同的股东群体。但要更好地理解奥麦罗制药,我们需要考虑许多其他因素。比如风险。每家公司都存在风险,我们发现了奥麦罗制药的5个警告信号(其中4个令人担忧!)你应该知道。
But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.
但最终,决定该业务所有者将获得多大利益的是未来而非过去。因此,我们认为最好查看此免费报告,以了解分析师是否预测更光明的未来。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的数据是使用最后一个财务报表日期结束的为期12个月的数据计算的。这可能与全年年度报告数据不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。